Home » Newsletters » BioWorld Asia

BioWorld Asia

April 19, 2000

View Archived Issues

Mergers, Alliances Help Improve Bottom Lines Of European Sector

Rat Study Shows Brain Stem Cells Could Deliver Therapies

European Parliament Votes For Tighter Restrictions On GMOs

Genset, Sanofi-Synthilabo Enter Pharmacogenomics Collaboration

Atugen Enters Target Validation Deal With Boehringer Ingelheim

Other News To Note

Founder Populations Elucidate Genetics Of Complex Disorders

Australian Center Opens To Make Chirally Pure Compounds

British Biotech Forms Alliance To Gets Access To U.S. Data

Geron Official Says UK Ban On Cloning Hinders Research

L'Orial Adopts Chemunex D-Scan Microbial Analyzer

Medigene Acquires Novel 'In Vitro Heart' Technology

Synt:em Confirms Potential Of Pep:trans Drug Delivery Method

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...